Hepatitis C

Ambulatory Conference Vishal Tiwari PGY 2 Thursday 22 May 2008

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object]

Source of presentation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],Hepatitis C

Screening ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

“Rule of 2’s” ,[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Lab Testing ,[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object]

Assays for HCV RNA ,[object Object],[object Object],[object Object],[object Object],[object Object]

HCV Genotyping ,[object Object],[object Object],[object Object]

Liver Biopsy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Liver Biopsy ,[object Object],[object Object],[object Object],[object Object]

Genotype and liver Biopsy ,[object Object],[object Object],[object Object],[object Object],[object Object]

Characteristics of persons for whom therapy is widely accepted ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Treatment Recommendations ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Optimal HCV treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Genotype 1 HCV infection ,[object Object],[object Object],[object Object]

Genotype-2 or Genotype -3 infection ,[object Object],[object Object],[object Object]

Adverse Events : Interferon Alfa ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Ribavarin ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Adverse Events ,[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Contraindications for Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Steps in managing and treating HCV Genotype 1 SVR

Steps in managing and treating HCV Genotype 2/3 SVR, ETR

Counseling ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Extra-hepatic complications of HCV ,[object Object],[object Object],[object Object]

Hepatitis C

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Viewers also liked

Viewers also liked (16)

Similar to Hepatitis C

Similar to Hepatitis C (20)

Recently uploaded

Recently uploaded (20)

Hepatitis C